TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06807359: Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

Sponsor: SpectraCure AB · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 43 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$9,778,230

Rescue Site Savings

+$6,440,280

Unlock Full NCT06807359 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06807359 Rescue Dossier →